Volume 147, Issue 5, Pages e3 (November 2014)

Slides:



Advertisements
Similar presentations
Volume 147, Issue 6, Pages e1 (December 2014)
Advertisements

Investigation of Outbreak of Infections Caused by Salmonella Saintpaul
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Huiqin He, Zhinong Jiang, Leimin Sun  Gastroenterology 
Reply Gastroenterology
Millie D. Long, Bruce E. Sands 
Individualized Medicine in Gastroenterology and Hepatology
Allergy to Surgical Implants
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Christoph Lübbert, Babett Holler  Gastroenterology 
Volume 135, Issue 4, Pages (October 2008)
Diagnosis of celiac sprue
Covering the Cover Gastroenterology
Evaluation and Management of End-Stage Liver Disease in Children
Volume 154, Issue 3, Pages e2 (February 2018)
Low Rates of Gastrointestinal and Non-Gastrointestinal Complications for Screening or Surveillance Colonoscopies in a Population-Based Study  Louise Wang,
Volume 147, Issue 4, Pages e7 (October 2014)
Volume 154, Issue 8, Pages (June 2018)
Pseudo-obstruction: Current approaches
Immune Reconstitution Inflammatory Syndrome of the Small Bowel in a Human Immunodeficiency Virus–Negative Patient  Severin Daum, Christoph Loddenkemper,
Prevalence of Irritable Bowel Syndrome–type Symptoms in Patients With Celiac Disease: A Meta-analysis  Anita Sainsbury, David S. Sanders, Alexander C.
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Volume 153, Issue 2, Pages e3 (August 2017)
Volume 145, Issue 1, Pages e8 (July 2013)
Cause-Specific Mortality of People With Barrett's Esophagus Compared With the General Population: A Population-Based Cohort Study  Masoud Solaymani–Dodaran,
Investigation of Outbreak of Infections Caused by Salmonella Saintpaul
Volume 147, Issue 6, Pages e1 (December 2014)
Volume 138, Issue 5, Pages e2 (May 2010)
Volume 153, Issue 3, Pages e16-e17 (September 2017)
Volume 154, Issue 4, Pages (March 2018)
Volume 147, Issue 3, Pages e2 (September 2014)
Reply Gastroenterology
Volume 152, Issue 1, Pages (January 2017)
Clinical Genomics in Inflammatory Bowel Disease
Effectiveness and Cost-effectiveness of Measuring Fecal Calprotectin in Diagnosis of Inflammatory Bowel Disease in Adults and Children  Zhuo Yang, Nick.
AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review  Jean-Frederic Colombel,
Jack C. O’Brien, Benjamin F. Chong 
In Vitro Fertilization in Women With Inflammatory Bowel Disease Is as Successful as in Women From the General Infertility Population  Sveta Shah Oza,
Population Health Management for Inflammatory Bowel Disease
Impact of New Hepatitis C Treatments in Different Regions of the World
Conventional Medical Management of Inflammatory Bowel Disease
Volume 148, Issue 5, Pages (May 2015)
Volume 155, Issue 3, Pages (September 2018)
Reenu Malhotra, Kevin Turner, Amnon Sonnenberg, Robert M. Genta 
Efficient Early Drug Development for Ulcerative Colitis
Targeting Smads to Restore Transforming Growth Factor-β Signaling and Regulatory T- Cell Function in Inflammatory Bowel Disease  Deanna D. Nguyen, Scott.
Volume 143, Issue 2, Pages e1 (August 2012)
Dushyant Singh, Reetu Singh, Wendell K. Clarkston 
Kathrine Frey Frøslie, Jørgen Jahnsen, Bjørn A. Moum, Morten H. Vatn 
Volume 136, Issue 5, Pages (May 2009)
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
Volume 150, Issue 5, Pages (May 2016)
Volume 141, Issue 1, Pages (July 2011)
Volume 149, Issue 6, Pages (November 2015)
Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis  Siddharth.
Volume 140, Issue 6, Pages e2 (May 2011)
Multiple Unusual Ulcerated Skin Lesions in a Crohn's Disease Patient
Risk of Cancer in Patients With Inflammatory Bowel Diseases: A Nationwide Population- based Cohort Study With 30 Years of Follow-up Evaluation  Michael.
Ethnicity Influences Phenotype and Outcomes in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis of Population-based Studies  Hai Yun.
Jack C. O’Brien, Benjamin F. Chong 
Meenakshi Bewtra, Chinyu Su, James D. Lewis 
Volume 145, Issue 6, Pages e2 (December 2013)
Daniel Mønsted Shabanzadeh, Lars Tue Sørensen, Torben Jørgensen 
Inflammatory Bowel Disease in African American Children Compared With Other Racial/Ethnic Groups in a Multicenter Registry  Jolanda M. White, Siobhán.
David J. Gracie, Elspeth A. Guthrie, P. John Hamlin, Alexander C. Ford 
Volume 138, Issue 6, Pages (May 2010)
Electronic Clinical Challenges and Images in GI
Tawfik Khoury, Eran Israeli, Shaul Yaari  Gastroenterology 
Volume 146, Issue 4, Pages (April 2014)
Abnormal Gastrointestinal Imaging in a Patient With Dyspepsia
Presentation transcript:

Volume 147, Issue 5, Pages 990-1007.e3 (November 2014) The Diagnostic Approach to Monogenic Very Early Onset Inflammatory Bowel Disease  Holm H. Uhlig, Tobias Schwerd, Sibylle Koletzko, Neil Shah, Jochen Kammermeier, Abdul Elkadri, Jodie Ouahed, David C. Wilson, Simon P. Travis, Dan Turner, Christoph Klein, Scott B. Snapper, Aleixo M. Muise  Gastroenterology  Volume 147, Issue 5, Pages 990-1007.e3 (November 2014) DOI: 10.1053/j.gastro.2014.07.023 Copyright © 2014 AGA Institute Terms and Conditions

Figure 1 Age of onset of IBD-like symptoms in patients with monogenic diseases. Multiple genetic defects are summarized in the group of atypical SCID, Hoyeraal–Hreidarsson syndrome, CGD, and Hermansky–Pudlak syndrome. By comparison, an unselected IBD population is presented (Oxford IBD cohort study; pediatric and adult referral-based IBD cohort, n = 1605 patients comprising CD, UC, and IBD unclassified [IBDU]). Symbols represent individual patients. Bars represent the age range of case series if individual data were not available. The age ranges of infantile IBD, VEOIBD, EOIBD, and Montreal/Paris classification A1a, A1b, A2, and A3 are shown for reference. Age of onset data refer to references provided in Table 2. Additional references for disease subgroups are provided in Supplementary Information for Figure 1. Gastroenterology 2014 147, 990-1007.e3DOI: (10.1053/j.gastro.2014.07.023) Copyright © 2014 AGA Institute Terms and Conditions

Figure 2 Diagnosis of VEOIBD. Patient and family history, physical examination, endoscopic investigations, imaging, and limited biochemistry and microbiology/virology tests are required to establish the diagnosis of IBD, assess disease localization and behavior, and determine inflammatory activity. If there is doubt, those tests can contribute to exclude the much more frequent gastrointestinal infections and non-IBD immune responses toward dietary antigens. Cow’s milk protein allergy can present with enteropathy and colitis, and celiac disease can mimic autoimmune enteropathies. Fecal calprotectin can be helpful but may be increased even in healthy infants. The current diagnostic strategy to investigate a monogenic cause of IBD-like intestinal inflammation is largely based on restricted functional screening followed by genetic confirmation. A restricted set of laboratory tests is needed to propose candidate genes of the most common genetic defects for subsequent limited sequencing. As a complementary approach, genetic screening for IBD-causative rare variants using next-generation sequencing might be followed by limited functional confirmatory studies. The complexity of problems in these children requires interdisciplinary support, including pediatric gastroenterologists, immunologists, geneticists, and infectious disease specialists. CBC, complete blood count; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; CMV, cytomegalovirus; TB, tuberculosis; HIV, human immunodeficiency virus; CMPA, cow’s milk protein allergy. Gastroenterology 2014 147, 990-1007.e3DOI: (10.1053/j.gastro.2014.07.023) Copyright © 2014 AGA Institute Terms and Conditions